Summary: Benchling announces AI acquisition.

Why It Matters: This shows Benchling is growing its AI tools.

What Changed:

• The news headline changed from "Merck and Benchling team up to modernize vaccine bioanalysis" to "Benchling acquires ReSync Bio and Sphinx Bio teams to accelerate AI in R&D."
• The link for the news changed from a Merck collaboration to an AI acquisition.